https://www.avient.com/sites/default/files/2020-12/excelite-1-page-case-study-grab-handle.pdf
Excelite OnePager Grab Handle (2) TIER 1 MOLDER A U T O M O T I V E G R A B H A N D L E • Reduce production cycle times • Achieve processing consistency in chemical foaming additive (CFA) performance • Control dimensional stability and reduce production scrap rates • Lower conversion costs • Improved cycle time by 20% • Achieved additional 2% density reduction • Resulted in a finer cell structure with a higher cell density, significantly improving dispersion and dimensional stability • Maintained Class A finish • Reduced CFA use rate by 80% Excelite™ IM Chemical Foaming Additives KEY REQUIREMENTS* WHY AVIENT?
https://www.avient.com/sites/default/files/2020-10/tpe-overmold-design-guide.pdf
TPE Substrate TPE Substrate Figure 2.
TPE mold temperatures of 70-120˚F (21-49˚C) are typical.
TPE mold temperatures of 70-120˚F (21-49˚C) are typical.
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_Elastomers_with_Universal_Bonding_Characteristics.pdf
The barrel temperature of the injection molding machine was set from 180°C to 235°C (360°F to 455°F) and the injection velocity from 15 mm/sec to 65 mm/sec.
TPE-1A peel adhesion 0 1 2 3 4 Pe el s tr en gt h: N /m m 190C 205C 220C 235C D040W6 Lexan 141 Cycolac NA1000 3 .1 2 .8 2 .8 2 .6 2 .1 2 .4 2 .4 2 .4 1.9 2 .1 2 .1 1.9 7 Figure 5.
TPE-1B peel adhesion 0 1 2 3 4 5 Pe el s tr en gt h: N /m m 190C 205C 220C 235C D040W6 Lexan 141 Cycolac NA1000 4 .3 4 .1 4 .0 3 .8 2 .9 3 .3 3 .1 2 .8 2 .8 2 .9 2 .8 2 .4 Figure 6.
https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-processing-guide.pdf
Increase shot size 2.
Increase shot size 2.
Increase gate size 2.
https://www.avient.com/resources/safety-data-sheets?page=7038
XRU-2947 FEP9494 CC HIGH WHITE - 10% F
XRU-2949 FEP9494 CC HIGH WHITE - 5% F
https://www.avient.com/resources/safety-data-sheets?page=4252
DNU Geon(TM) A53-99B Bo-Tuff Solid Strand F
DNU Geon(TM) A53-99A Bo-Light Foam Strand F
https://www.avient.com/sites/default/files/2020-05/2.-polyone-ir-presenstation-wells-fargo-industrials-conference.pdf
https://www.avient.com/sites/default/files/2023-05/Mevopur Amber for PET Pharma Pkg Application Bulletin_CN _2.pdf
https://www.avient.com/sites/default/files/2024-10/Final 2_Avient Semicondcutor Packaging Case Study Snapshot 2024.pdf
https://www.avient.com/sites/default/files/2022-08/AVNT Aug 2022 Presentation - Jefferies.pdf
AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) AU G U S T 2 0 2 2 DISCLAIMER 2 Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
WHAT WE DO: MATERIAL SCIENCE 5 CUSTOM FORMULATION SUSTAINABILITY FOR A BETTER TOMORROW Revenue From Sustainable Solutions* 2016-2021 $310 205 140 80 75 45 40 20 $915M2021 Sales ($ in millions) *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12% 6 S E CO N D Q UART E R 2022 RE S U LT S $122 $134 2021 2022 $0.87 $0.98 2021 2022 Q2 2022 PERFORMANCE (TOTAL COMPANY) 8 Sales Adjusted Operating Income $1,235 $1,302 2021 2022 + 5% Adjusted EPS + 10% + 13% (in millions) (in millions) (+ 10% excluding FX) (+ 16% excluding FX) (+ 20% excluding FX) Q2 2022 SEGMENT PERFORMANCE 9 CAI $624 $649 Sales ($ in millions) SEM Distribution $86 $94 Operating Income + 4% + 9% $404 $443 Sales $24 $27 Operating Income + 10% + 13% (1) $241 $244 Sales $37 $37 Operating Income + 1% Flat (+ 10% excluding FX) (+ 16% excluding FX) (+ 6% excluding FX) (+ 3% excluding FX) Q2 2021 $1,235 $122 Sustainable Solutions 17 7% 7 Healthcare 23 14% 5 Composites (ex Outdoor High Performance) 10 20% 4 Growth in Asia / LATAM 5 3% 1 Other 69 11% 5 Sub-total $1,359 10% $144 Outdoor High Performance Impact (9) (5) Wage Inflation and Overtime (7) Other Supply Chain Costs (2) Clariant Color Integration Synergies 7 Incentives, Other Employee Costs 4 FX (48) (7) Q2 2022 $1,302 5% $134 Q2 2022 SALES AND OPERATING INCOME (TOTAL COMPANY) 10 Sales Growth Rate Adjusted Operating Income$ millions Adjusted EBITDA Q2 EBITDA BRIDGE 11 Price increases more than offsets raw material and supply chain impacts Q2 2021 $ 159 Demand (29) $ millions CAI: Price / Mix 87 Inflation (58) SEM: Price / Mix 36 Inflation (24) Distribution: Price / Mix 45 Inflation (41) Net Price Benefit 45 Wage Inflation and Overtime (7) Other Supply Chain Costs (2) Clariant Color Integration Synergies 7 Incentives, Other Employee Costs 4 FX (7) Q2 2022 $ 170 China Lockdowns / Russia Impact $ (14) Outdoor High Performance (5) Transportation (5) 12 Q2 '21 Adjusted EPS 0.87$ Color, Additives and Inks 0.11 Specialty Engineered Materials 0.01 Distribution 0.03 Corporate Costs 0.01 F/X (0.05) Segment OI 0.11$ Interest Expense 0.03 Tax Rate (0.03) Q2 '22 Adjusted EPS 0.98$ Q2 EPS BRIDGE Key Updates • Provided progress on 2030 Sustainability Goals • Emphasized commitment to U.N.
EPS (ex Amort) 3.96$ 0.13$ 4.09$ (0.58)$ 3.51$ Pro Forma Leverage (12/31/2022E) Net Debt / Adjusted EBITDA 1.6x 3.4x 2.8x Forecast Dyneema Forecast + Dyneema Sale of Distribution Pro Forma 2022 TWO-YEAR LEVERAGE MODEL 20 3.5x 2.7x 1.6x 2.8x 2.4x 2.0x 2019PF 2020PF 2022E 2022PF 2023E 2024E Dyneema® AcquisitionClariant Color Acquisition (1) Pro forma for the acquisition of the Clariant Color business (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution, including repayment of senior notes due 2023 and Term Loan (1) (1) (2) OUR SPECIALTY JOURNEY CONTINUES 21 • Dyneema® brings leading technology and brand with the World’s Strongest Fiber™, deep history of application development and strong management team focused on specialty applications • Dyneema® transaction is aligned with our previously stated acquisition goal of expanding our composites and fiber capabilities • Similar to our other technology expansion acquisitions, Dyneema® allows us to leverage our invest-to-grow strategy • The possible sale of our Distribution business also presents potential benefits with respect to leverage and EBITDA margins 7% 46% 66% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2021 2022 PF % o f A dj us te d EB IT D A(1 ) JVs Distribution Performance Products & Solutions Specialty (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution (2) Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET TRANSFORMATION TO LESS CYCLICAL INDUSTRIES (W ITH DY N EEM A , EX .